Organon (OGN) Receivables (2020 - 2026)

Organon's Receivables history runs 7 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

• In Q1 2026, Receivables fell 5.01% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $1.4 billion (down 5.01% YoY), while the FY2025 annual figure was $1.3 billion, down 1.99% from the prior year.
• Receivables was $1.4 billion for Q1 2026 at Organon, up from $1.3 billion in the prior quarter.
• In the past five years, Receivables ranged from a high of $1.9 billion in Q2 2022 to a low of $1.3 billion in Q4 2025.
• Historically, Receivables has averaged $1.6 billion across 5 years, with a median of $1.6 billion in 2023.
• Biggest YoY gain for Receivables was 66.34% in 2022; the steepest drop was 23.22% in 2022.
• A 5-year view of Receivables shows it stood at $1.8 billion in 2022, then declined by 5.68% to $1.7 billion in 2023, then retreated by 22.13% to $1.4 billion in 2024, then retreated by 1.99% to $1.3 billion in 2025, then rose by 3.98% to $1.4 billion in 2026.
• The last three Receivables figures came in at $1.4 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.